Jeffrey A. Bailey - 09 Mar 2022 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC

Role
Chief Executive Officer, Director
Signature
Jeffrey A Bailey
Issuer symbol
N/A
Transactions as of
09 Mar 2022
Net transactions value
$0
Form type
4
Filing time
11 Mar 2022, 07:08:52 UTC
Previous filing
31 Jan 2022
Next filing
22 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSI Common Stock Options Exercise $0 +5,333 +5.3% $0.000000 105,133 09 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSI Restricted Stock Units Options Exercise $0 -5,333 -50% $0.000000 5,334 09 Mar 2022 Common Stock 5,333 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were acquired by the Reporting Person as a result of the vesting of 5,333 of RSUs granted to the Reporting Person on March 9, 2020 under the Issuer's 2019 Stock Option Incentive Plan. The remainder of the RSUs under this grant will vest on March 9, 2023.